In the wake of a major reorganization that resulted in more than 100 layoffs, Austin-based clinical-stage cancer drug company Molecular Templates Inc. is overhauling a chunk of its executive suite.
In the wake of a major reorganization that resulted in more than 100 layoffs, Austin-based clinical-stage cancer drug company Molecular Templates Inc. is overhauling a chunk of its executive suite.
